Erdafitinib’s effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer
暂无分享，去创建一个
J. P. Perez Ruixo | D. Ouellet | I. Poggesi | A. Dosne | P. De Porre | E. Valade | K. Stuyckens | Lilian Y. Li | A. Avadhani | A. O’Hagan | R. Faelens | Quentin Leirens | Anne O’Hagan | Juan Jose Perez Ruixo